Insights

Innovative Therapeutics Sylentis specializes in gene silencing and RNA interference therapies for ophthalmologic conditions like glaucoma and dry eye syndrome, presenting opportunities for biopharmaceutical and medical device partnerships focused on ophthalmology.

European Market Focus Based in Madrid and actively developing advanced eye treatments, Sylentis offers potential collaboration prospects in European healthcare markets, especially with providers and clinics seeking innovative ophthalmic solutions.

Strong Industry Connections As a subsidiary of PharmaMar, Sylentis benefits from established industry links, opening avenues for joint research initiatives, clinical trial support, and distribution collaborations within the biotech and pharmaceutical sectors.

Growing R&D Presence With a dedicated focus on gene-based therapies and recent leadership additions, Sylentis presents opportunities to support R&D tools, technological solutions, and contract research services tailored to biotech innovation.

Financial Opportunity Operating with a revenue range of 1 to 10 million dollars, Sylentis could be interested in strategic financing, licensing deals, or technology investments to accelerate product development and expand its ophthalmic treatment portfolio.

SYLENTIS Tech Stack

SYLENTIS uses 8 technology products and services including WordPress, Microsoft 365, Google Fonts API, and more. Explore SYLENTIS's tech stack below.

WordPress

Content Management System

Microsoft 365

Google Fonts API

Font Scripts

spin.js

Javascript Frameworks

Isotope

Javascript Libraries

DPD

Logistics

Bootstrap

UI Frameworks

Google Analytics

Web Analytics

SYLENTIS Email Formats	Example	Percentage
FLast@sylentis.com	JDoe@sylentis.com	100%

SYLENTIS Email Formats

Example

Percentage

FLast@sylentis.com

JDoe@sylentis.com

100%

Frequently Asked Questions

Where is SYLENTIS's headquarters located?

SYLENTIS's main headquarters is located at 2 c Santiago Grisolía Humanes de Madrid, Community of Madrid 28760 Spain. The company has employees across 1 continents, including Europe.

What is SYLENTIS's phone number?

You can contact SYLENTIS's main corporate office by phone at

+34-918-04-7****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SYLENTIS's official website and social media links?

SYLENTIS's official website is sylentis.com and has social profiles on LinkedIn Crunchbase.

What is SYLENTIS's SIC code NAICS code?

SYLENTIS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SYLENTIS have currently?

As of April 2026, SYLENTIS has approximately 60 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: A. S.Head Of Clinical Operations: A. B.Head Of Regulatory Affairs: V. R.. Explore SYLENTIS's employee directory with LeadIQ.

What industry does SYLENTIS belong to?

SYLENTIS operates in the Biotechnology Research industry.

What technology does SYLENTIS use?

SYLENTIS's tech stack includes WordPressMicrosoft 365Google Fonts APIspin.jsIsotopeDPDBootstrapGoogle Analytics.

What is SYLENTIS's email format?

SYLENTIS's email format typically follows the pattern of FLast@sylentis.com. Find more SYLENTIS email formats with LeadIQ.

When was SYLENTIS founded?

SYLENTIS was founded in 2006.

SYLENTIS

Q: What is SYLENTIS's official website and social media links?

SYLENTIS's official website is sylentis.com. SYLENTIS has social profiles on LinkedIn.

Q: How many employees does SYLENTIS have currently?

SYLENTIS has approximately 60 employees.

Q: What technology does SYLENTIS use?

SYLENTIS's tech stack includes Essential Addons for Elementor, spin.js, DPD, MySQL, Ubuntu.

Q: What is SYLENTIS's NAICS code?

SYLENTIS's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCommunity of Madrid, Spain51-200 Employees

Sylentis is an European biotechnological company founded in 2006. Sylentis focuses on researching new therapeutic approaches based on gene silencing. Our company is specialised in developing ophtalmologic   therapies via interference RNA, a powerful tool for rational drug design.

Most advanced product of the company are treatments for glaucoma and dry eye syndrome.

Sylentis is a wholly owned member of PharmaMar (www.pharmamar.com)

Insights

Similar companies to SYLENTIS

Aptuit

Selvita

Immunocore

Axxam S.p.A

SYLENTIS Tech Stack

Media & News

Sylentis hires Andreas Segerros as Chief Executive Officer.

SYLENTIS's Email Address Formats